金双歧联用思密达治疗小儿腹泻的疗效观察  

Clinical Analysis of Treating Infantile Diarrhea with Fructooligosacchdrye Combined Smectite

作　　者：马小艳[1] 余霞辉[1] 冷惠[1] 

机构地区：[1]四川省崇州市人民医院儿科,611230

出　　处：《临床合理用药杂志》2013年第27期56-57,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的观察金双歧联用思密达治疗小儿腹泻的疗效。方法分别选取2011年1月—2013年1月以及2007年12月—2010年12月收治的腹泻患儿各100例,分别列为观察组与对照组,在基本治疗的基础上,分别采用金双歧联用思密达以及维生素B和乳酶生治疗,对比两组疗效。结果两组疗效比较差异有统计学意义(P<0.05)。结论金双歧联用思密达治疗小儿腹泻临床效果显著,安全可靠,值得临床推广。Objective To analzye the effect of treating 100 cases of infantile diarrhea with fructooligosacchdrye combined smectite.Methods Choosed 100 cases of infantile diarrhea from Jan.2011 to Jan.2013 and Dec.2007 to Dec.2010 to divide into study group and controlled group.Study group were treated with fructooligosacchdrye combined smectite and controlled group were treated with VB and lactasin.Compared the effect and safety of these two groups.Results The total effective rate in study group was higher than the other group.Conclusion The effect of treating infantile diarrhea with fructooligosacchdrye combined smectite is significant and safe to extend in clinic.

关 键 词：金双歧 思密达 腹泻 治疗结果 

分 类 号：R725.7[医药卫生—儿科]